IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
89.37
-0.46 (-0.51%)
Oct 15, 2026, 4:00 PM EDT - Market closed
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, IRADIMED CORPORATION stock has a consensus rating of "Buy" and an average price target of $118. The average 1-year stock price forecast is 32.04% higher than the current stock price, while the lowest is $116 (+29.80%) and the highest is $120 (+34.27%).
Price Target: $118 (+32.04%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 3, 2026.
Analyst Ratings
The average analyst rating for IRADIMED CORPORATION stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 22, 2026 |
| Lake Street | Lake Street | Buy Reiterates $120 | Buy | Reiterates | $120 | +34.27% | Aug 3, 2026 |
Financial Forecast
Revenue This Year
92.07M
from 83.81M
Increased by 9.85%
Revenue Next Year
104.10M
from 92.07M
Increased by 13.07%
EPS This Year
2.11
from 1.93
Increased by 9.50%
EPS Next Year
2.45
from 2.11
Increased by 16.09%
EPS and Forward PE are based on non-GAAP adjusted numbers.